Clinical trial
Efgartigimod for the Treatment of Acute Optic Neuritis
NCT06453694
Study timeline
Study start (actual)2025-08-12Date precision: day
Registry last updated2025-11-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Optic Neuritisunresolved
Interventions
Efgartigimod AlfaDRUG · verified · RxNorm: efgartigimod alfa
PlaceboDRUG
Sponsors & collaborators
Anastasia Vishnevetsky, MD, MPHlead sponsor
argenxcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06453694 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.